Insider · CIK 0001800060

Jones Michael L

Reports to the SEC for 1 company · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001800060

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-12-19	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Exec. Director, Finance - PAO	AAward	+5,900 sh	—	—	16,653
2022-12-19	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Exec. Director, Finance - PAO	AAward	+8,500 sh	—	—	8,500
2022-12-15	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Exec. Director, Finance - PAO	SSale	−445 sh	$10.90	−$4,850.5	10,753
2022-12-01	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Exec. Director, Finance - PAO	MExercise/Conversion	+8,600 sh	$1.42	+$12.2K	19,798
2022-12-01	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Exec. Director, Finance - PAO	SSale	−8,600 sh	$13.01	−$112K	11,198
2022-12-01	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Exec. Director, Finance - PAO	MExercise/Conversion	−8,600 sh	—	—	0
2022-03-01	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Exec. Director, Finance - PAO	MExercise/Conversion	+2,300 sh	$4.73	+$10.9K	13,498
2022-03-01	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Exec. Director, Finance - PAO	SSale	−2,300 sh	$17.20	−$39.6K	11,198
2022-03-01	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Exec. Director, Finance - PAO	MExercise/Conversion	−2,300 sh	—	—	0
2021-12-14	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Exec. Director, Finance - PAO	AAward	+5,850 sh	—	—	11,198
2021-12-14	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Exec. Director, Finance - PAO	AAward	+11.7K sh	—	—	11,700
2021-03-18	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Exec. Director, Finance - PAO	MExercise/Conversion	+4,500 sh	$3.51	+$15.8K	5,348
2021-03-18	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Exec. Director, Finance - PAO	MExercise/Conversion	−4,500 sh	—	—	0
2020-12-15	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Exec. Director, Finance - PAO	AAward	+30K sh	—	—	30,000
2020-12-03	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Exec. Director, Finance - PAO	AAward	+5,000 sh	—	—	5,000
2020-02-21	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Exec. Director, Finance - PAO	AAward	+2,800 sh	—	—	2,800
2020-02-14	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Exec. Director, Finance - PAO	AAward	+4,900 sh	—	—	4,900

Recent filings

Accepted (ET)
Dec 214
Jones Michael L0001127602-22-028078
SEC(opens sec.gov)
Dec 194
Jones Michael L0001127602-22-027870
SEC(opens sec.gov)
Dec 24
Jones Michael L0001127602-22-026834
SEC(opens sec.gov)
Mar 34
Jones Michael L0001127602-22-008047
SEC(opens sec.gov)
Dec 164
Jones Michael L0001127602-21-031141
SEC(opens sec.gov)
Mar 224
Jones Michael L0001127602-21-011668
SEC(opens sec.gov)
Dec 174
Jones Michael L0001127602-20-031800
SEC(opens sec.gov)
Dec 74
Jones Michael L0001127602-20-030706
SEC(opens sec.gov)
Feb 254
Jones Michael L0001127602-20-007687
SEC(opens sec.gov)
Feb 194
Jones Michael L0001127602-20-006508
SEC(opens sec.gov)

Companies

BIOCRYST PHARMACEUTICALS INCExec. Director, Finance - PAOBCRX

Address

4505 EMPEROR BLVD. SUITE 200

DURHAM, NC, 27703